XML 37 R9.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Consolidated Statement of Cash Flows Consolidated Statements of Cash Flows - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Cash flows - operation activities:    
Net (loss)/earnings $ (641) $ 2,149
Non-cash items -    
Share-based plans expense 55 47
Depreciation and amortization 556 521
Investment/asset impairment charges, net 26 34
Customer financing valuation adjustments 249
Other charges and credits, net (54) (108)
Other charges and credits, net 97 74
Changes in assets and liabilities -    
Accounts receivable (54) 206
Unbilled receivables (402) (183)
Advances and progress billings 1,337 1,857
Inventories 2,973 2,725
Other current assets 328 164
Accounts payable (1,030) 1,624
Accrued liabilities (583) (919)
Income taxes receivable, payable and deferred (892) 116
Other long-term liabilities (69) (281)
Pension and other postretirement plans (179) (188)
Customer financing, net 23 152
Other 153 (1)
Net cash (used)/provided by operating activities (4,302) 2,788
Cash flows - investing activities:    
Property, plant and equipment additions (428) (501)
Property, plant and equipment reductions 58 110
Acquisitions, net of cash acquired (276)
Contributions to investments (244) (457)
Proceeds from investments 227 366
Other 8 (9)
Net cash used by investing activities (379) (767)
Cash flows - financing activities:    
New borrowings 17,433 5,237
Debt repayments (5,854) (4,374)
Contributions from noncontrolling interests 7
Stock options exercised 21 42
Employee taxes on certain share-based payment arrangements (162) (233)
Common shares repurchased (2,341)
Dividends paid (1,158) (1,161)
Net cash provided/(used) by financing activities 10,280 (2,823)
Effect of exchange rate changes on cash and cash equivalents, including restricted (47) 1
Net increase/(decrease) in cash & cash equivalents, including restricted 5,552 (801)
Cash & cash equivalents, including restricted, at beginning of year 9,571 7,813
Cash & cash equivalents, including restricted, at end of period 15,123 7,012
Restricted Cash and Cash Equivalents (84) [1] (176)
Cash and cash equivalents at end of period $ 15,039 $ 6,836
[1]
(2) 
Reflects amounts restricted in support of our workers’ compensation programs, employee benefit programs, and insurance premiums.